Brookstone Capital Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,773
Closed -$128K 874
2023
Q2
$128K Sell
10,773
-8,664
-45% -$98.6K ﹤0.01% 799
2023
Q1
$227K Sell
19,437
-14,146
-42% -$175K ﹤0.01% 762
2022
Q4
$445K Sell
33,583
-19,090
-36% -$243K 0.01% 604
2022
Q3
$657K Sell
52,673
-257
-0.5% -$3.8K 0.02% 510
2022
Q2
$758K Buy
52,930
+2,568
+5% +$34.3K 0.02% 474
2022
Q1
$685K Buy
50,362
+8,923
+22% +$122K 0.01% 489
2021
Q4
$593K Buy
41,439
+10,102
+32% +$143K 0.01% 477
2021
Q3
$468K Buy
31,337
+6,532
+26% +$110K 0.01% 513
2021
Q2
$451K Buy
24,805
+9,802
+65% +$175K 0.01% 503
2021
Q1
$260K Buy
+15,003
New +$264K 0.01% 422

Other funds holding SBRA

Brookstone Capital Management's SBRA Position: Q3 2023 in Review

Brookstone Capital Management sold out of Sabra Healthcare REIT (SBRA) in Q3 2023, closing a stake of 10,773 shares — an estimated $128K sold.

Brookstone Capital Management first reported a position in SBRA in Q1 2021 and held it in 10 quarters. The position peaked at $758K in Q2 2022. 329 funds tracked by Wall St. Rank hold SBRA as of Q3 2023.

  • Brookstone Capital Management reported no remaining Sabra Healthcare REIT position as of Q3 2023 after selling out during the quarter.
  • Brookstone Capital Management sold 10,773 Sabra Healthcare REIT shares in Q3 2023, an estimated $128K.
  • Brookstone Capital Management first reported a position in Sabra Healthcare REIT in Q1 2021 and held it in 10 quarters.
  • Brookstone Capital Management's Sabra Healthcare REIT position peaked at $758K in Q2 2022.
  • 329 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2023.

Based on Brookstone Capital Management's 13F filing for Q3 2023, filed 20 Oct 2023.